Cargando…
Role of artificial intelligence in peptide vaccine design against RNA viruses
RNA viruses have high rate of replication and mutation that help them adapt and change according to their environmental conditions. Many viral mutants are the cause of various severe and lethal diseases. Vaccines, on the other hand have the capacity to protect us from infectious diseases by elicitin...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536498/ https://www.ncbi.nlm.nih.gov/pubmed/34722851 http://dx.doi.org/10.1016/j.imu.2021.100768 |
_version_ | 1784588019381043200 |
---|---|
author | Mohanty, Eileena Mohanty, Anima |
author_facet | Mohanty, Eileena Mohanty, Anima |
author_sort | Mohanty, Eileena |
collection | PubMed |
description | RNA viruses have high rate of replication and mutation that help them adapt and change according to their environmental conditions. Many viral mutants are the cause of various severe and lethal diseases. Vaccines, on the other hand have the capacity to protect us from infectious diseases by eliciting antibody or cell-mediated immune responses that are pathogen-specific. While there are a few reviews pertaining to the use of artificial intelligence (AI) for SARS-COV-2 vaccine development, none focus on peptide vaccination for RNA viruses and the important role played by AI in it. Peptide vaccine which is slowly coming to be recognized as a safe and effective vaccination strategy has the capacity to overcome the mutant escape problem which is also being currently faced by SARS-COV-2 vaccines in circulation.Here we review the present scenario of peptide vaccines which are developed using mathematical and computational statistics methods to prevent the spread of disease caused by RNA viruses. We also focus on the importance and current stage of AI and mathematical evolutionary modeling using machine learning tools in the establishment of these new peptide vaccines for the control of viral disease. |
format | Online Article Text |
id | pubmed-8536498 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85364982021-10-25 Role of artificial intelligence in peptide vaccine design against RNA viruses Mohanty, Eileena Mohanty, Anima Inform Med Unlocked Article RNA viruses have high rate of replication and mutation that help them adapt and change according to their environmental conditions. Many viral mutants are the cause of various severe and lethal diseases. Vaccines, on the other hand have the capacity to protect us from infectious diseases by eliciting antibody or cell-mediated immune responses that are pathogen-specific. While there are a few reviews pertaining to the use of artificial intelligence (AI) for SARS-COV-2 vaccine development, none focus on peptide vaccination for RNA viruses and the important role played by AI in it. Peptide vaccine which is slowly coming to be recognized as a safe and effective vaccination strategy has the capacity to overcome the mutant escape problem which is also being currently faced by SARS-COV-2 vaccines in circulation.Here we review the present scenario of peptide vaccines which are developed using mathematical and computational statistics methods to prevent the spread of disease caused by RNA viruses. We also focus on the importance and current stage of AI and mathematical evolutionary modeling using machine learning tools in the establishment of these new peptide vaccines for the control of viral disease. The Authors. Published by Elsevier Ltd. 2021 2021-10-23 /pmc/articles/PMC8536498/ /pubmed/34722851 http://dx.doi.org/10.1016/j.imu.2021.100768 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Mohanty, Eileena Mohanty, Anima Role of artificial intelligence in peptide vaccine design against RNA viruses |
title | Role of artificial intelligence in peptide vaccine design against RNA viruses |
title_full | Role of artificial intelligence in peptide vaccine design against RNA viruses |
title_fullStr | Role of artificial intelligence in peptide vaccine design against RNA viruses |
title_full_unstemmed | Role of artificial intelligence in peptide vaccine design against RNA viruses |
title_short | Role of artificial intelligence in peptide vaccine design against RNA viruses |
title_sort | role of artificial intelligence in peptide vaccine design against rna viruses |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536498/ https://www.ncbi.nlm.nih.gov/pubmed/34722851 http://dx.doi.org/10.1016/j.imu.2021.100768 |
work_keys_str_mv | AT mohantyeileena roleofartificialintelligenceinpeptidevaccinedesignagainstrnaviruses AT mohantyanima roleofartificialintelligenceinpeptidevaccinedesignagainstrnaviruses |